Two drugmakers are appealing a Washington, D.C. federal district judge's ruling against unilateral 340B rebate models.

Two Drugmakers Appeal Federal District Judge’s 340B Rebate Ruling in Favor of HHS

May 30, 2025 William Newton, Associate Editor/Senior Writer Views

Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!